ArticleVaccines2021
Who Is Really at Risk for Anaphylaxis Due to COVID-19 Vaccine?
Article in Vaccines, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 24 citations in OpenAlex.
- Impact of SARS-CoV-2 on Severe Asthma Patients Undergoing Biological Therapy: A Multicenter Study.Journal of clinical medicine · 2025Article
- Knife's edge: Balancing immunogenicity and reactogenicity in mRNA vaccines.Experimental & molecular medicine · 2023Review
- [Vaccination approach in patients with an allergic reaction to COVID-19 vaccines or at risk of developing allergic reactions].Tuberkuloz ve toraks · 2023Article
- COVID-19 vaccine provocation test outcome in high-risk allergic patients: A retrospective study from a tertiary hospital in Indonesia.The World Allergy Organization journal · 2023Article
- Administration of BNT162b2 mRNA COVID-19 vaccine to subjects with various allergic backgrounds.Frontiers in immunology · 2023Article
- Allergic Reactions to COVID-19 Vaccines: Risk Factors, Frequency, Mechanisms and Management.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy · 2022Review
- A Case Report of Prolonged Anaphylaxis after COVID-19 Vaccine.Clinical practice and cases in emergency medicine · 2022Article
- Suspected Anaphylactic Reaction Following Second Dose of the Pfizer-BioNTech (BNT162b2) Coronavirus Vaccine in a Geriatric Female.HCA healthcare journal of medicine · 2022Article
- Safety & effectiveness of COVID-19 vaccines: A narrative review.The Indian journal of medical research · 2022Review
- Parents' hesitation about getting their children vaccinated against COVID-19 in Japan.Human vaccines & immunotherapeutics · 2021Article
- COVID-19 Vaccination in Patients with Severe Asthma on Biologic Treatment: Safety, Tolerability, and Impact on Disease Control.Vaccines · 2021Article
- Vaccination hesitancy and the "myth" on mRNA-based vaccines in Italy in the COVID-19 era: Does urgency meet major safety criteria?Journal of medical virology · 2021Article
- COVID-19 Vaccine-associated Anaphylaxis and Allergic Reactions: Consensus Statements of the KAAACI Urticaria/Angioedema/Anaphylaxis Working Group.Allergy, asthma & immunology research · 2021Review
- Adverse reactions to COVID-19 vaccines: A practical approach.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2021Review
- Review the safety of Covid-19 mRNA vaccines: a review.Patient safety in surgery · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The vaccination campaign against the Severe acute respiratory syndrome coronavirus 2 (Sars-Cov-2) started on 8 December 2020 in UK, after the approval of BNT162b2 by the Healthcare products Regulatory Agency (MHRA) [...].
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.